• 1
    IARC. Monographs on the evaluation of carcinogenic risks to humans: human papillomaviruses. Lyon: IARC Scientific Publications, 1995.
  • 2
    Walboomers JMM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cancer worldwide. J Pathol 1999;189: 129.
  • 3
    Meijer CJLM, Snijders PJF, Brule AJC. Screening for cervical cancer: should we test for infection with high-risk HPV? Can Med Ass J 2000;163: 5358.
  • 4
    Ho GYF, Burk RD, Klein S, et al. Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. J Natl Cancer Inst 1995;87: 136571.
  • 5
    Nobbenhuis MAE, Walboomers JMM, Helmerhorst Th JM, et al. Relation of human papillomavirus status to cervical lesions and consequences for cervical cancer screening: a prospective study. Lancet 1999;354: 205.
  • 6
    Schiffman MH. Epidemiology of cervical human papillomavirus infections. In: zur HausenH, ed. Human pathogenic papillomaviruses. Current topics in microbiology and immunology. Berlin: Springer Verlag 1994; 5581.
  • 7
    Walboomers JMM, Jacobs MV, van Oostveen JW, et al. Detection of human papillomavirus infections and possible clinical implications. In: GrossG, von KroghG, eds. Human papillomavirus infections in dermatovenereology. Boca Raton, FL: CRC Press, 1997; 34164.
  • 8
    Cuzick J, Terry G, Ho L, et al. Type-specific human papillomavirus DNA in abnormal scrapes as a predictor of high-grade cervical intraepithelial neoplasia. Br J Cancer 1994;69: 16771.
  • 9
    Cuzick J, Terry G, Ho L, et al. Human papillomavirus type 16 DNA in cervical scrapes as predictor of high-grade cervical cancer. Lancet 1992;339: 95960.
  • 10
    Bavin PJ, Giles JA, Deery A, et al. Use of semi-quantitative PCR for human papillomavirus DNA type 16 to identify women with high grade cervical disease in a population presenting with a mildly dyskaryotic scrape report. Br J Cancer 1993;67: 6025.
  • 11
    Flanelly G, Jiang G, Anderson D, et al. 1995. Serial quantitation of HPV 16 in the scrapes of women with mild and moderate dyskaryosis. J Med Virol 1995;47: 69.
  • 12
    Farthing A, Masterson P, Mason WP, et al. Human papillomavirus detection by hybrid capture and its possible clinical use. J Clin Pathol 1994;47: 64952.
  • 13
    Clavel C, Masure M, Levert M, et al. Human papillomavirus detection by the hybrid capture II assay: a reliable test to select women with normal cervical scrapes at risk for developing cervical lesions. Diag Mol Pathol 2000;9: 14550.
  • 14
    Clavel C, Masure M, Bory JP, Putaud I, Mangeonjean C, Lorenzato M, et al. Hybrid capture II-based human papillomavirus detection, a sensitive test to detect in routine high-grade cervical lesions: a preliminary study on 1518 women. Br J Cancer 1999;80: 130611.
  • 15
    George SS, Luthra UK, Chishti M, et al. Distribution of human papillomaviruses in women. Med Prin Prac 2000;9: 10612.
  • 16
    Sun XW, Ferenczy A, Johnson D, et al. Evaluation of the hybrid capture human papillomavirus deoxyribonucleic acid detection test. Am J Obstet Gynecol 1995;173: 14327.
  • 17
    Joseffson AM, Magnusson PKE, Ylitalo N, et al. 2000. Viral load of human papillomavirus 16 as a determinant for development of cervical carcinoma in situ: a nested case-control study. Lancet 2000;355: 218993.
  • 18
    Rozendaal L, Walboomers JMM, Van der Linden JC, et al. 1996. PCR-based high-risk HPV test in cervical cancer screening gives objective risk assessment of women with cytomorphologically normal cervical smears. Int J Cancer 1996;68: 7669.
  • 19
    Hopman EH, Rozendaal L, Voorhorst FJ, et al. High-risk human papillomavirus in women with normal cervical cytology prior to the development of abnormal cytology and colposcopy. Br J Oncol Gynecol 2000;107: 6004.
  • 20
    Remmink AJ, Walboomers JMM, Helmerhorst Th JM, et al. 1995. The presence of persistent high-risk HPV genotypes in dysplastic cervical lesions is associated with progressive disease: natural history up to 36 months. Int J Cancer 1995;61: 30611.
  • 21
    Van den Brule AJC, Meijer CJLM, Bakels V, et al. Rapid human papillomavirus detection in cervical scrapes by combined general primer-mediated and type-specific polymerase chain reaction. J Clin Microbiol 1990;28: 273943.
  • 22
    Jacobs MV, Walboomers JMM, van Beek J, et al. A quantitative polymerase chain reaction-enzyme immunoassay for accurate measurements of human papillomavirus type 16 DNA levels in cervical scrapings. Br J Cancer 1999;81: 11421.
  • 23
    Zielinski GD, Snijders PJF, Rozendaal L, et al. 2001. High-risk HPV testing in women with borderline and mild dyskaryosis: long term follow-up data and clinical relevance. J Pathol 2001;195: 3006.
  • 24
    Nobbenhuis MAE, Helmerhorst Th JM, van den Brule AJC, et al. Cytological regression and clearance of high-risk human papillomavirus in women with an abnormal smear. Lancet 2001;358: 17823.
  • 25
    Ylitalo N, Sørensen P, Joseffson AM, et al. Consistent high viral load of human papillomavirus 16 and risk of cervical carcinoma in situ: a nested case-control study. Lancet 2000;355: 21948.